Impact of Acute Dopamine Replacement on Cognitive Function in Parkinson's Disease.

Joseph SeemillerChristopher MorrowJared Thomas HinkleKate PerepezkoVidyulata KamathGregory M PontoneKelly A Mills

Published in: Movement disorders clinical practice (2024)

Symptomatic medication differentially affects performance on two cognitive tests in PD. After acute treatment, core Stroop measures improved, Stroop interference was unchanged, and SDMT performance worsened, likely reflecting complex changes in processing speed and executive function related to acute treatment. When considering motor symptom therapies in PD, an individual's cognitive demands and expectations, especially regarding executive function, should be considered.

Keyphrases

liver failure
respiratory failure
healthcare
emergency department
metabolic syndrome
intensive care unit
combination therapy
uric acid
hepatitis b virus
adverse drug
patient reported